The cluster is broad and conviction-driven, with both passive and active managers adding. The $250K insider buy adds corroboration. However, the 45-day 13F lag means positions may have been partially unwound. Monitor for a catalyst (e.g., pipeline update) that could explain the shared thesis, and watch for follow-on insider buying or further 13F accumulation in Q3.
CRVS drugs
CRVS drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 21 $14.46entry
- T+1 · 3mo ago −2.56%α −2.26% · $14.09
- T+5 · 3mo ago −2.07%α −2.55% · $14.16
- T+20 · 8w ago −14.11%α −13.58% · $12.42
- T+60 · 20h ago −26.69%α −23.33% · $10.60
How similar events traded
Executive Summary
A strong institutional cluster formed in CRVS during 2026-Q2, with 15 buyers accumulating $24.8M in holdings (net +$14.6M) against only 3 sellers trimming $17.1M. The buying was dominated by mega-passive firms (BofA, Wells Fargo, UBS) and active asset managers (Susquehanna, Citigroup) doubling or adding positions, while the selling was concentrated in a single large trim by Morgan Stanley (-$16.5M). The cluster is reinforced by a 13F × Form 4 confluence score of 65/100 ('conviction'), with one insider making a $250K open-market purchase, suggesting shared conviction around a catalyst.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$2.5M
▲ Buyers (15)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| BofA | DOUBLED | +219.7% | $11.3M | $7.9M |
| Susquehanna International Group | DOUBLED | +393.4% | $2.8M | $2.3M |
| Citigroup | DOUBLED | +676.8% | $1.7M | $1.5M |
| UBS | ADD | +37% | $5.9M | $1.7M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -46.2% | $36.6M | -$16.5M |
| Td Asset Management | TRIM | -33.2% | $1.8M | -$576.3K |
Key Facts
- 15 institutional buyers vs 3 sellers in 2026-Q2
- Aggregate buyer holdings: $24.8M (net change +$14.6M)
- BofA doubled its position (+219.7%) to $11.3M, the largest buyer
- Susquehanna (+393.4%) and Citigroup (+676.8%) also doubled positions
- Morgan Stanley trimmed 46.2% of its stake, selling $16.5M
- 13F × Form 4 confluence score 65/100, one insider bought $250K open-market
- 93% of analysts rate the stock Buy or Strong Buy
Financial Impact
15 institutions accumulated $24.8M in CRVS during Q2, with net buying of $14.6M, while 3 sellers reduced holdings by $17.1M (net cluster -$2.5M)
Risk Factors
- 13F data is 45+ days stale; cluster may have already been unwound
- Morgan Stanley's large trim (-$16.5M) offsets much of the buying
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CRVS-2026-Q2 |
Track record
15 reports on CRVS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 13, 20263d ago Insider Buy Neutral 3/10 Entry $11.20 settles Feb 12
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $11.37 settles Feb 8
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $10.54 settles Feb 4
- Nov 5, 202611d ago Press Release Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $10.57 settles Feb 2
- Sep 30, 20266w ago Press Release Neutral 3/10 Entry $10.93 settles Dec 28
- Aug 21, 202612w ago Institutional Cluster Bullish 6/10 Viewing Entry $14.46 to $10.60 ▼ −26.69% −23.33% vs SPY
- Jul 22, 202616w ago 8-K Neutral 2/10 Entry $13.68 to $9.85 ▼ −28.00% −32.55% vs SPY
- Jun 11, 202622w ago Institutional Cluster Neutral 3/10 Entry $11.60 to $14.39 ▲ +24.05% +19.66% vs SPY
- May 14, 202626w ago 8-K Bullish 7/10 Entry $13.66 to $13.74 ▲ +0.62% −2.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers